63
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
AL-108
AL-108, 5 mg/day- one spray in each nostril once per day
AL-108
AL-108, 30 mg/day- 3 sprays in each nostril, twice per day
Placebo
Placebo- 3 sprays in each nostril, twice per day
Placebo
Placebo- one spray in each nostril, once per day
Columbia University Medical Center, New York
Nathan Kline Institute, Orangeburg
Maryland Psychiatric Research Center, Catonsville
Duke University Medical Center, Durham
Washington University School of Medicine, St Louis
UCLA, Los Angeles
Massachusetts General Hospital, Boston
Harvard Medical School, Boston
Collaborators (1)
University of Maryland
OTHER
Washington University School of Medicine
OTHER
Massachusetts General Hospital
OTHER
Nathan Kline Institute for Psychiatric Research
OTHER
Columbia University
OTHER
Duke University
OTHER
Beth Israel Deaconess Medical Center
OTHER
University of California, Los Angeles
OTHER